George Tidmarsh

George Francis Tidmarsh was the founder of Threshold Pharmaceuticals, Inc. (2001), serving as President; Nuveta, Inc. (2009), serving as President & Chief Executive Officer; Horizon Therapeutics, Inc. (2005), serving as Director; Metronome Therapeutics, Inc. (2006), serving as Chief Executive Officer; and Horizon Pharma, Inc. (2005), serving as President.
Current jobs include Chairman at Revelation Biosciences Sub, Inc., Director at Lucile Packard Foundation for Children’s Health since 2018, Director at Citizens Oncology Foundation, and Associate Professor-Neonatology at Stanford University School of Medicine since 2010.
Former jobs include President, CEO, Secretary & Director at La Jolla Pharmaceutical Co. (2012-2019), Chief Executive Officer at Solana Therapeutics, Inc. (2011-2012), Chairman at Revelation Biosciences, Inc. (2020-2025), Chairman at Prospect Therapeutics, Inc., Director at InfaCare Pharmaceutical Corp., Executive Director at Anavex Life Sciences Corp.
(2011-2012), Director at Odonate, Inc. (2016-2019), Principal at Gilead Sciences, Inc., Principal at SEQUUS Pharmaceuticals, Inc., Principal at Systemix, Inc., Chief Scientific Officer & Senior Vice President at Spectrum Pharmaceuticals, Inc. (2010-2011), and Chief Medical Officer at Coulter Pharmaceuticals, Inc. (1996-2000).
Education includes a doctorate from Stanford University (1982) and a doctorate from Stanford University School of Medicine (1988).